# Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/adalimumab-etanercept-infliximab-rituximab-and-abatacept-for-the-treatment-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | K Malottki,Pelham Barton,A Tsourapas,Olalekan A. Uthman,Zhihong Liu,K Routh,Martin Connock,Paresh Jobanputra,David Moore,A Fry-Smith,Y-F Chen |
| Citations | 287 |
| DOI | 10.3310/hta15140 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://njl-admin.nihr.ac.uk/document/download/2002101 |
| OpenAlex ID | https://openalex.org/W2102987799 |
| PMID | 21439251 |
| Type | review |
| Year | 2011 |

## Paper authors

- [Martin Connock](https://scholariq.org/researchers/martin-connock/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.